EPH75 Adverse Event Types and Discontinuation Rate of Alzheimer's Medication Approved by United States Food and Drug Administration (USFDA)
| Autor: | Almutairi, R., Sanogo, V., Diaby, K. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S216-S216 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect